Immuno-proteomic screening demonstrated that elevated titers of auto-antibodies to the cancer-testis antigens (CTAG2) are correlated with diverse cancer types and suggest decreased differentiation in cancer cells (Kaaks et al., 2018). This evidence concerns the gene CTAG2 and cancer.